Business Context and Reporting Period
Company: Acadia Healthcare Company, Inc.
Filing Type: Form 8-K (Current Report)
Date: February 2, 2016
Context: The filing discloses a proposed private offering of senior unsecured notes and updates to the company's risk factors.
Key Financial Metrics
This filing does not report specific revenue, profit, cash flow, or margin figures for a completed period. The primary financial metric disclosed is the proposed debt issuance:
- Proposed Debt Offering: $390 million aggregate principal amount of senior unsecured notes due 2024.
- Offering Structure: Unregistered offering pursuant to Rule 144A to qualified institutional buyers and Regulation S to non-U.S. persons.
- Historical/Pro Forma Data: The filing references attached exhibits (99.2 and 99.3) containing historical condensed consolidated financial data and unaudited pro forma condensed combined financial data, but the specific numerical values are not included in the text of this report.
Material Changes
Debt Capitalization: The company is proposing to increase its debt load by $390 million through the issuance of the Senior Notes.
Risk Factors: The company has revised certain risk factors previously disclosed in its current and periodic reports (detailed in Exhibit 99.4).
Guidance, Outlook, and Risks
Management Commentary: The filing includes a press release (Exhibit 99.1) announcing the proposed note offering. A confidential offering memorandum is being furnished to prospective buyers.
Forward-Looking Statements: The document contains forward-looking statements regarding the proposed offering, identified by terms such as "anticipate," "believe," "expect," and "plan."
Risks and Contingencies:
- Actual results may differ materially from forward-looking statements due to risks and uncertainties outside the company's control.
- The company disclaims any obligation to update forward-looking statements.
- Revised risk factors are attached as Exhibit 99.4.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific terms of the $390 million note offering.
- Examine the "Unaudited Pro Forma Condensed Combined Financial Information" (Exhibit 99.3) to understand the impact of the new debt on the company's leverage and liquidity.
- Read the "Revised Risk Factors" (Exhibit 99.4) to identify new or updated risks affecting the business.
- Verify the final pricing and interest rate of the Senior Notes, as this filing only announces the proposal.